Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
Chae‐Ok Yun, JinWoo Hong, A‐Rum Yoon
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Dequan Liu, Xiangyu Che, Xiaoxi Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1384-1384
Open Access | Times Cited: 29
Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?
Christianne Groeneveldt, Jasper van den Ende, Nadine van Montfoort
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 1-12
Open Access | Times Cited: 26
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
Palaniyandi Muthukutty, So Young Yoo
Viruses (2023) Vol. 15, Iss. 8, pp. 1645-1645
Open Access | Times Cited: 24
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 14
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 11
New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Development and application of oncolytic viruses as the nemesis of tumor cells
Xiao Zhu, Chenyang Fan, Zhuolong Xiong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 18
Smart Accumulating Dual-Targeting Lipid Envelopes Equipping Oncolytic Adenovirus for Enhancing Cancer Gene Therapeutic Efficacy
Yuebin Zhao, Thai Minh Duy Le, JinWoo Hong, et al.
ACS Nano (2024)
Closed Access | Times Cited: 4
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 4
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy
Nicholas S. Giacobbi, Shreya Mullapudi, Harrison Nabors, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 302-302
Open Access | Times Cited: 4
Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report
Xiaoming Zhang, Jingyu Chen, Jie Sun, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 3
Co‐delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro‐chemotherapeutic approach
Sadia Anjum, Faiza Naseer, Tahir Ahmad, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Closed Access | Times Cited: 3
miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses
Мария Сергеевна Торопко, Sergey Chuvpilo, Alexander Karabelsky
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 986-986
Open Access | Times Cited: 3
Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment
Aleksander Gryciuk, Marta Rogalska, Joanna Baran, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1947-1947
Open Access | Times Cited: 8
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 8
Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
Alisa B. Ageenko, Natalia S. Vasileva, Vladimir A. Richter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2042-2042
Open Access | Times Cited: 2
Zika Virus: A Neurotropic Warrior against High-Grade Gliomas—Unveiling Its Potential for Oncolytic Virotherapy
María-Angélica Calderón-Peláez, Silvia Maradei Anaya, Ingrid Bedoya-Rodríguez, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 561-561
Open Access | Times Cited: 2
2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus
Pavel O. Vorobyev, Д. В. Кочетков, Peter M. Chumakov, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5611-5611
Open Access | Times Cited: 11
Emergent and underexplored oncolytic viruses for treating pediatric central nervous system tumors
Isabela Granha, Gustavo Sartorelli, Oswaldo Keith Okamoto, et al.
EJC Paediatric Oncology (2024) Vol. 3, pp. 100151-100151
Open Access | Times Cited: 1
Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy
In-Wook Kim, A‐Rum Yoon, JinWoo Hong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma
Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, et al.
Nanomedicine (2024) Vol. 19, Iss. 15, pp. 1389-1406
Closed Access | Times Cited: 1
Virus nanotechnology for intratumoural immunotherapy
Anthony O. Omole, Zhongchao Zhao, Sabrina Chang-Liao, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 916-929
Closed Access | Times Cited: 1
Nature Killer Cell for Solid Tumors: Current obstacles and prospective remedies in NK cell therapy and beyond
Jia‐Hao Tao, Jun Zhang, Huashun Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104553-104553
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top